Diabetes and weight loss drug semaglutide has been trialled in people with Alzheimer's. We explain what it means for dementia ...
New analysis from Alzheimer’s Research UK has revealed that dementia remained the UK’s leading cause of death in 2024, ...
A FAT jab could help slow down Alzheimer’s by slashing brain shrinkage, according to a small British study. Liraglutide, the ...
New research suggests that unusual changes in eating behavior—rather than memory loss—may be one of the earliest signs of a ...
Dear J.A.: Yes, you can develop shingles. The only chicken pox vaccine licensed is a live, weakened strain of the chicken pox ...
MedPage Today on MSN
Novel Alzheimer's Pill May Slow Decline in Some High-Risk Patients
Valiltramiprosate is a brain-penetrant small molecule that blocks amyloid from aggregating into toxic oligomers, which are ...
GLP-1 agonist drugs essentially mimic the hormone’s action. Quite a few have been developed, including semaglutide, ...
India’s pharmaceutical giants are hoping to earn fat profits as their customers get thinner. With the patent for blockbuster diabetes and weight-loss drugs Ozempic and Wegovy set to expire in March, ...
Science supports the first two claims, but the third, a supposed change in penis size, is the one that’s capturing attention: ...
GLP-1 medication, such as Wegovy, was added to the list of ‘essential’ medicines by the World Health Organization in ...
Three women caring for loved ones open up about grief, loss of identity, and what gets them through the hardest times.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results